Head of TA Access Strategy

About the role

The TA Access Strategy Head leads the development and execution of an integrated, market-specific access and pricing strategy across the product lifecycle. The role ensures timely, sustainable and differentiated patient access by shaping value strategies, guiding cross-functional teams and engaging key external stakeholders to support optimal reimbursement and long-term market access. It is based in Barcelona or Madrid, on a hybrid basis, and Novartis does not offer relocation support.

Key responsibilities

• Develop and lead the integrated access and pricing strategy for the therapeutic area across launch and lifecycle, aligning value proposition, positioning and access ambition.
• Provide access input into pipeline and Target Product Profiles, guiding indication sequencing, affordability considerations and early access hypotheses.
• Define pricing, contracting and negotiation strategies to achieve optimal reimbursement and sustainable access outcomes.
• Lead cross-functional coordination with Commercial, Medical, HEOR/HTA, Regulatory, Policy and Field teams, and prepare early access inputs up to 36 months pre-launch.
• Build strong relationships with payers, health authorities and other stakeholders, representing Novartis in negotiations and policy discussions.
• Shape healthcare system readiness and access landscape strategies, including private market and alternative funding approaches.
• Provide access leadership across pipeline, launch and in-market assets, including lifecycle management, HTA updates and pricing reviews.
• Gather market, payer and field insights to refine strategy and inform portfolio decisions.
• Lead and develop high-performing teams and matrix partners.

Required profile

• University degree in life sciences, health economics, public health, business or a related field; advanced degree preferred.
• Fluent English and Spanish required.
• 7 to 10 years of extensive experience in market access, pricing or related disciplines.
• Proven leadership experience managing teams of more than 10 people.
• Track record of developing integrated access and pricing strategies for innovative medicines across the lifecycle.
• Experience engaging with payers, HTA bodies, health authorities and external decision-makers.

Required skills

• Pipeline and early access strategy, including evidence needs and clinical design considerations.
• Strong analytical, strategic and scenario-planning capabilities.
• Negotiation, stakeholder management and value story communication.
• Ability to lead complex initiatives in matrix environments and operate effectively under ambiguity.